Molnár Andrea Ágnes, Birgés Kristóf, Surman Adrienn, Merkely Béla
Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary.
Int J Mol Sci. 2024 Dec 8;25(23):13185. doi: 10.3390/ijms252313185.
Cardiovascular diseases and cancer represent the largest disease burden worldwide. Previously, these two conditions were considered independent, except in terms of cardiotoxicity, which links cancer treatment to subsequent cardiovascular issues. However, recent studies suggest that there are further connections between cancer and heart disease beyond cardiotoxicity. It has been revealed that myocardial dysfunction may promote carcinogenesis, indicating that additional common pathophysiological mechanisms might be involved in the relationship between cardiology and oncology, rather than simply a connection through cardiotoxic effects. These mechanisms may include shared risk factors and common molecular pathways, such as persistent inflammation and neurohormonal activation. This review explores the connection between myocardial dysfunction and cancer, emphasizing their shared risk factors, similar biological mechanisms, and causative factors like cardiotoxicity, along with their clinical implications.
心血管疾病和癌症是全球最大的疾病负担。以前,这两种疾病被认为是相互独立的,除了在心脏毒性方面,心脏毒性将癌症治疗与随后的心血管问题联系起来。然而,最近的研究表明,除了心脏毒性之外,癌症和心脏病之间还有进一步的联系。研究发现,心肌功能障碍可能促进癌症发生,这表明心脏病学和肿瘤学之间的关系可能涉及更多共同的病理生理机制,而不仅仅是通过心脏毒性效应建立的联系。这些机制可能包括共同的风险因素和共同的分子途径,如持续炎症和神经激素激活。本综述探讨了心肌功能障碍与癌症之间的联系,强调了它们共同的风险因素、相似的生物学机制以及心脏毒性等致病因素,以及它们的临床意义。